Metabolites in Cancer

Oncogenomics is a sub field of genomics that portrays disease related qualities. It centers on genomic, epigenomic and transcript adjustments in growth. Malignancy is a hereditary malady caused by assemblage of DNA changes and epigenetic adjustments prompting uncontrolled cell multiplication and neoplasm advancement. The objective of oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new dreams into disease conclusion, expecting clinical aftereffect of developments and new focuses for malignancy treatments.

Cancer SocietiesChildren's Cancer AssociationFrench Society of Oncology PharmacyFrench Society of Oncology PharmacyBelgian Association of Oncological RadiotherapyCancer Registry BavariaEuropean Cancer Organization.

 

    Related Conference of Metabolites in Cancer

    October 04-05, 2023

    8th Global Summit on Cancer Science and Oncology

    Barcelona, Spain
    November 08-09, 2023

    International Conference on Cancer Biology and Therapeutics

    Budapest, Hungary
    November 15-16, 2023

    36th Conference on Preventive Oncology and Diagnostic Cancer

    Edinburgh, Scotland
    December 14-15, 2023

    5th International Conference on Oncology and Cancer

    Rome, Italy
    February 22-23, 2024

    14th World Congress on Breast Cancer

    Zurich, Switzerland
    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    March 21-22, 2024

    8th Global Meeting on Oncology and Radiology

    Paris, France
    April 18-19, 2024

    24th World Congress on Cancer and Diagnostics

    Dubai, UAE

    Metabolites in Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in